SynVivo Appoints Dr. Richard Eglen to Board of Directors

HUNTSVILLE, Ala., May 21, 2025 (GLOBE NEWSWIRE) — SynVivo, a pioneering organ-on-chip company developing advanced microfluidic platforms that replicate human tissue microenvironments for drug discovery, today announced the appointment of Dr. Richard Eglen as a non-executive member of its Board of Directors. Dr. Eglen brings over 40 years of leadership experience in the life sciences […]

SynVivo Appoints Dr. Richard Eglen to Board of Directors

SynVivo Appoints Dr. Richard Eglen to Board of Directors GlobeNewswire May 21, 2025 HUNTSVILLE, Ala., May 21, 2025 (GLOBE NEWSWIRE) — SynVivo, a pioneering organ-on-chip company developing advanced microfluidic platforms that replicate human tissue microenvironments for drug discovery, today announced the appointment of Dr. Richard Eglen as a non-executive member of its Board of Directors.

GCL Announces ‘JDM: Japanese Drift Master’ Worldwide Launch

(NASDAQ:GCL), SINGAPORE, May 21, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced the highly anticipated launch of “JDM: Japanese Drift Master” that is regionally published and distributed in Asia by GCL's game publishing subsidiary 4Divinity. After several years in active

GCL Announces ‘JDM: Japanese Drift Master’ Worldwide Launch

GCL Announces 'JDM: Japanese Drift Master' Worldwide Launch GlobeNewswire May 21, 2025 SINGAPORE, May 21, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced the highly anticipated launch of “JDM: Japanese Drift Master” that is regionally published and distributed in Asia

Vianai Collaborates with SAP to Bring Together Gen AI Tools

The collaboration builds on the strengths of the SAP Joule copilot, the just ask feature of SAP Analytics Cloud, and hila, and seeks to fundamentally transform analytics on enterprise data Vianai Systems, Inc. today announced at SAP Sapphire in Orlando a collaboration with SAP to bring together the best generative AI capabilities of the SAP

Optimizely and commercetools Launch Partnership to Modernize Enterprise Retail Experiences

Strategic partnership provides enterprise retailers with a composable, future-ready foundation to deliver personalized digital experiences faster Optimizely, the leading digital experience platform (DXP) provider, today announced a strategic technology partnership with unified commerce platform commercetools, designed to transform how enterprise B2C retailers deliver digital experiences. By combining Optimizely's content management, personalization, experimentation, and AI capabilities

Traders Fair Philippines 2025: The Ultimate Destination for Traders and Investors

MANILA, Philippines, May 21, 2025 (GLOBE NEWSWIRE) — Traders Fair Philippines, the leading financial event in the region, is set to return to Manila in 2025 for another exciting edition. Organized by iEvents, Traders Fair Philippines brings together traders, investors, brokers, exchanges, and financial service providers under one roof for a full day of high-quality

Traders Fair Philippines 2025: The Ultimate Destination for Traders and Investors

Traders Fair Philippines 2025: The Ultimate Destination for Traders and Investors GlobeNewswire May 21, 2025 MANILA, Philippines, May 21, 2025 (GLOBE NEWSWIRE) — Traders Fair Philippines, the leading financial event in the region, is set to return to Manila in 2025 for another exciting edition. Organized by iEvents, Traders Fair Philippines brings together traders, investors,

Best Online Casinos for Pokies in Australia: Highflybet Chosen as The Top AU Pokie Site

New York City, NY, May 21, 2025 (GLOBE NEWSWIRE) — Finding the best online pokies casino in Australia means choosing a site that delivers real value–top-tier games, fast payouts, and a smooth experience tailored to AU players. Highflybet Casino checks every box, offering a massive selection of pokies, reliable support, and full AUD functionality. With

Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19

(NasdaqGM:IVVD), FDA acknowledges that the benefit of repeat doses of COVID-19 vaccine boosters for Americans is uncertain; the updated regulatory framework for COVID-19 vaccines articulated by the Agency generally aligns with recent Invivyd Citizen Petition requests In contrast to vaccine boosters, monoclonal antibody (mAb) therapies, including pemivibart, underwent contemporary randomized, placebo-controlled trials to evaluate safety,

Scroll to Top